Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
p = 0.063), also with high heterogeneity (I 2 = 87%)
Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes and manage chronic weight in adults with obesity
GLP-1 users often cut back on alcohol, so mocktails, flavored waters, and protein-enhanced drinks become your new profit centers
Although the absolute risk remains relatively low, studies show a modest but consistent increase in gallstones and cholecystitis among treated patients compared to placebo
US$ 21.33
US$ 27.61
US$ 24.44
US$ 23.85
US$ 22.33
US$ 21.57
